CGTX
Price
$0.70
Change
-$0.05 (-6.67%)
Updated
Oct 22 closing price
Capitalization
66.62M
14 days until earnings call
Intraday BUY SELL Signals
LTRN
Price
$0.64
Change
-$0.04 (-5.88%)
Updated
Oct 22 closing price
Capitalization
8.19M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGTX vs LTRN

CGTX vs LTRN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CGTX vs. LTRN commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a Hold and LTRN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CGTX with price predictions
Oct 22, 2026

CGTX sees MACD Histogram just turned negative

CGTX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 22, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 41 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CGTX as a result. In 91 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

CGTX moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CGTX crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CGTX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where CGTX advanced for three days, in 164 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

CGTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.017) is normal, around the industry mean (2.973). P/E Ratio (-4.121) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. CGTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for LTRN with price predictions
Oct 22, 2026

LTRN in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 24, 2026

LTRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 40 of 45 cases where LTRN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for LTRN just turned positive on October 13, 2026. Looking at past instances where LTRN's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.

Following a +6.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where LTRN advanced for three days, in 199 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for LTRN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.546) is normal, around the industry mean (2.973). P/E Ratio (-0.393) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. LTRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LTRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
LTRN: Fundamental Ratings
LTRN
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXLTRN
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CGTX: $0.75 vs. LTRN: $0.68)
Brand notoriety: CGTX and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 73% vs. LTRN: 58%
Market capitalization -- CGTX: $66.62M vs. LTRN: $8.19M
CGTX [@Biotechnology] is valued at $66.62M. LTRN’s [@Biotechnology] market capitalization is $8.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 2 FA rating(s) are green while LTRN’s FA Score has 2 green FA rating(s).

  • CGTX’s FA Score: 2 green, 3 red.
  • LTRN’s FA Score: 2 green, 3 red.
According to our system of comparison, both CGTX and LTRN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 4 TA indicator(s) are bullish while LTRN’s TA Score has 4 bullish TA indicator(s).

  • CGTX’s TA Score: 4 bullish, 6 bearish.
  • LTRN’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than CGTX.

Price Growth

CGTX (@Biotechnology) experienced а -3.88% price change this week, while LTRN (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

CGTX is expected to report earnings on Nov 05, 2026.

LTRN is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CGTX
Daily Signal:
Gain/Loss:
LTRN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGTX has been loosely correlated with RCKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CGTX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
-6.16%
RCKT - CGTX
42%
Loosely correlated
+5.00%
MGX - CGTX
38%
Loosely correlated
-1.52%
SYRE - CGTX
38%
Loosely correlated
-0.67%
SANA - CGTX
35%
Loosely correlated
+0.85%
PROK - CGTX
35%
Loosely correlated
-0.69%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ALZN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-6.40%
ALZN - LTRN
39%
Loosely correlated
-10.40%
AXON - LTRN
36%
Loosely correlated
+2.98%
CGTX - LTRN
34%
Loosely correlated
-6.16%
WHWK - LTRN
32%
Poorly correlated
-1.07%
CCCC - LTRN
31%
Poorly correlated
+0.32%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSCO5.130.02
+0.39%
FS Credit Opportunities Corp
QMY26.14N/A
N/A
Corgi Growth & Technology 10% Structured Buffer ETF - May Series (QMY)
NVBW36.78-0.16
-0.42%
AllianzIM U.S. Equity Buffer20 Nov ETF (NVBW)
KOID32.48-1.43
-4.22%
KraneShares Global Humanoid Robotics and Physical AI Index ETF (KOID)
BAVA24.83-2.01
-7.50%
Bitwise Avalanche ETF (BAVA)